🇺🇸 FDA
Pipeline program

Levobupivacaine

PCEA-LEVO-ROPI

Approved small_molecule active

Quick answer

Levobupivacaine for Arthroplasty, Replacement, Knee is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
Arthroplasty, Replacement, Knee
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials